139 related articles for article (PubMed ID: 9924364)
1. Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patients.
Verbraak FD; van den Horn GJ; van der Meer JT; Paydafar D; ten Kate FJ; Wertheim-van Dillen PM; Kijlstra A
Br J Ophthalmol; 1998 Jul; 82(7):748-50. PubMed ID: 9924364
[TBL] [Abstract][Full Text] [Related]
2. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
3. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
Berman SM; Kim RC
Am J Med; 1994 May; 96(5):415-9. PubMed ID: 8192172
[TBL] [Abstract][Full Text] [Related]
4. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
[TBL] [Abstract][Full Text] [Related]
8. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Roarty JD; Fisher EJ; Nussbaum JJ
Ophthalmology; 1993 Nov; 100(11):1685-8. PubMed ID: 8233395
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
10. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.
Hodge WG; Lalonde RG; Sampalis J; Deschênes J
J Infect Dis; 1996 Aug; 174(2):393-6. PubMed ID: 8699072
[TBL] [Abstract][Full Text] [Related]
11. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
12. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
13. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
14. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
16. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
18. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of CMV.
Cheng B
PI Perspect; 1995 May; (no 16):12-3. PubMed ID: 11362420
[TBL] [Abstract][Full Text] [Related]
20. Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
Jabs DA; Martin BK; Forman MS;
Ophthalmology; 2010 Jan; 117(1):128-132.e2. PubMed ID: 19818505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
